FR3048614B1 - Cellules souches stromales derivees du tissu adipeux pour une utilisation dans le traitement des fistules peri-anales complexes refractaires dans la maladie de crohn - Google Patents

Cellules souches stromales derivees du tissu adipeux pour une utilisation dans le traitement des fistules peri-anales complexes refractaires dans la maladie de crohn Download PDF

Info

Publication number
FR3048614B1
FR3048614B1 FR1752073A FR1752073A FR3048614B1 FR 3048614 B1 FR3048614 B1 FR 3048614B1 FR 1752073 A FR1752073 A FR 1752073A FR 1752073 A FR1752073 A FR 1752073A FR 3048614 B1 FR3048614 B1 FR 3048614B1
Authority
FR
France
Prior art keywords
crohn
disease
treatment
stem cells
fistulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1752073A
Other languages
English (en)
French (fr)
Other versions
FR3048614A1 (enExample
Inventor
Eduardo BRAVO
Maria PASCUAL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Tigenix SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tigenix SA filed Critical Tigenix SA
Publication of FR3048614A1 publication Critical patent/FR3048614A1/fr
Application granted granted Critical
Publication of FR3048614B1 publication Critical patent/FR3048614B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1752073A 2016-03-14 2017-03-14 Cellules souches stromales derivees du tissu adipeux pour une utilisation dans le traitement des fistules peri-anales complexes refractaires dans la maladie de crohn Active FR3048614B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB16043044 2016-03-14
GBGB1604304.4A GB201604304D0 (en) 2016-03-14 2016-03-14 Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease

Publications (2)

Publication Number Publication Date
FR3048614A1 FR3048614A1 (enExample) 2017-09-15
FR3048614B1 true FR3048614B1 (fr) 2020-02-21

Family

ID=55952284

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1752073A Active FR3048614B1 (fr) 2016-03-14 2017-03-14 Cellules souches stromales derivees du tissu adipeux pour une utilisation dans le traitement des fistules peri-anales complexes refractaires dans la maladie de crohn

Country Status (27)

Country Link
US (3) US10357518B2 (enExample)
EP (2) EP3219321B1 (enExample)
JP (2) JP6931656B2 (enExample)
KR (1) KR102277789B1 (enExample)
CN (2) CN115569151A (enExample)
AU (1) AU2017232718B2 (enExample)
BE (1) BE1024781B1 (enExample)
CA (1) CA3017694C (enExample)
CY (1) CY1125513T1 (enExample)
DE (1) DE102017002458B4 (enExample)
DK (1) DK3219321T3 (enExample)
ES (2) ES2911718T3 (enExample)
FR (1) FR3048614B1 (enExample)
GB (2) GB201604304D0 (enExample)
HR (1) HRP20220539T1 (enExample)
HU (1) HUE058739T2 (enExample)
IL (2) IL261730B2 (enExample)
LT (1) LT3219321T (enExample)
MX (1) MX2018010699A (enExample)
NL (1) NL2018512B1 (enExample)
NO (1) NO345415B1 (enExample)
PL (1) PL3219321T3 (enExample)
RS (1) RS63163B1 (enExample)
RU (1) RU2742308C2 (enExample)
SG (2) SG11201807404XA (enExample)
SI (1) SI3219321T1 (enExample)
WO (1) WO2017158509A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3601531B1 (en) 2017-03-30 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with live biotherapeutics
AU2020228979B2 (en) * 2019-02-27 2025-05-29 Takeda Pharmaceutical Company Limited Improved stem cell populations for allogeneic therapy
CA3170915A1 (en) * 2020-03-11 2021-09-16 Mesoblast International Sarl Method for treating inflammatory bowel disease i
US20230104108A1 (en) * 2020-03-11 2023-04-06 Mesoblast International Sárl Method for treating inflammatory bowel disease ii
CN111481573A (zh) * 2020-03-26 2020-08-04 卡替（上海）生物技术股份有限公司 牙髓间充质干细胞在制备克罗恩病治疗药物中的用途
WO2022115609A1 (en) * 2020-11-25 2022-06-02 Flagship Pioneering, Inc. Adipogenic cell compositions and methods
EP4531879A1 (en) * 2022-05-25 2025-04-09 Flagship Pioneering Innovations VI, LLC Compositions of secretory and/or catalytic cells and methods using the same

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
FR2680931B1 (fr) 1991-08-27 1997-08-14 Thomson Csf Procede de detection et de suivi d'objets en mouvement par analyse de sequences d'images.
BR9307550A (pt) 1992-12-02 1999-05-25 Shell Int Research Composto fungicida processo para a preparação de um composto fungicida composição fungicida processo de combate aos fungos em um local e uso
WO1995002698A1 (en) 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
US5472183A (en) 1994-03-17 1995-12-05 Nisca Corporation Sheet feeding device with multiple sheet stackers
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
EP0952792B1 (en) 1994-06-06 2003-08-27 Case Western Reserve University Biomatrix for tissue regeneration
EP0832271B8 (en) 1995-06-07 2005-03-02 INEX Pharmaceuticals Corp. Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US5744335A (en) 1995-09-19 1998-04-28 Mirus Corporation Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
US6546106B2 (en) 1996-09-03 2003-04-08 New Transducers Limited Acoustic device
US5705308A (en) 1996-09-30 1998-01-06 Eastman Kodak Company Infrared-sensitive, negative-working diazonaphthoquinone imaging composition and element
AU1615599A (en) 1997-12-02 1999-06-16 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US9585916B2 (en) 1999-03-26 2017-03-07 Northern Therapeutics Inc. Cell based therapy for the pulmonary system
ES2205792T3 (es) 1998-04-03 2004-05-01 Osiris Therapeutics, Inc. Celulas madre mesenquimatosas como inmunosupresores.
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US20050153442A1 (en) 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
KR100979664B1 (ko) 1999-03-10 2010-09-02 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 지방 유래 간세포 및 격자
CN1201268C (zh) 1999-06-30 2005-05-11 国际商业机器公司 实现运动模糊化的图像处理
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
CA2438904C (en) 2001-02-23 2012-09-04 The University Of Pittsburgh Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
AU2002356935A1 (en) 2001-11-09 2003-05-19 Artecel Sciences, Inc. Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
CZ2004696A3 (cs) * 2001-11-09 2005-02-16 Artecel Sciences, Inc. Endokrinní pankreatická diferenciace buněk stromatu odvozených z adipózní tkáně a její použití
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
AU2003267949A1 (en) 2002-03-15 2003-12-31 U.S. Government As Represented By The Department Of Veterans Affairs Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
AU2003239016B2 (en) 2002-06-14 2007-09-20 Xintela Ab Marker for stem cells and its use
US20040101959A1 (en) 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
DE602004029337D1 (de) 2003-04-01 2010-11-11 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
CA2530421C (en) 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
US7645229B2 (en) 2003-09-26 2010-01-12 Armstrong David N Instrument and method for endoscopic visualization and treatment of anorectal fistula
JP4749331B2 (ja) 2003-10-07 2011-08-17 株式会社バイオマスター 脂肪由来前駆細胞の細胞分化
DE602004030823D1 (de) 2003-11-04 2011-02-10 Biomaster Inc Verfahren und system zur herstellung von stammzellen aus fettgewebe
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP2298863B1 (en) 2004-03-22 2015-07-22 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
RU2252252C1 (ru) 2004-04-09 2005-05-20 Тепляшин Александр Сергеевич Способ выделения мезенхимальных стволовых клеток
ES2264862B8 (es) 2004-08-25 2017-01-20 Cellerix, S.L. Biomaterial para sutura.
US20060045872A1 (en) * 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
WO2006029347A2 (en) 2004-09-03 2006-03-16 University Of Maryland, Baltimore Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
JP5925408B2 (ja) 2005-09-23 2016-05-25 タイジェニックス、ソシエダッド、アノニマ、ウニペルソナルＴｉｇｅｎｉｘ Ｓ．Ａ．Ｕ． 免疫調節活性を有する細胞集団、単離方法および使用
EP1795588A1 (en) 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
US20120269774A1 (en) 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20110262402A1 (en) 2007-09-07 2011-10-27 Masahiko Kuroda Therapeutic and prophylactic agents for arthritis
RU2709780C2 (ru) 2007-09-19 2019-12-20 Плуристем Лтд. Адгезивные клетки жировой ткани или плаценты и их использование в лечебных целях
ES2595103T3 (es) 2007-10-17 2016-12-27 Txcell Células Tr1, células madre mesenquimales y usos de estas
GB0814249D0 (en) 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
ES2345867B1 (es) * 2009-04-03 2011-07-28 Fundacion Instituto Mediterraneo Para La Biotecnologia Y La Investigacion Sanitaria (Imabis) Celulas madre multipotentes derivadas de estroma de mesenterio.
WO2010126194A1 (ko) * 2009-04-28 2010-11-04 (주) 안트로젠 누공 치료를 위한 자가 및 동종의 지방 유래 스트로마 줄기세포 조성물
BR112012000534A2 (pt) 2009-07-09 2017-06-13 Cellerix Sa métodos e composições para uso em terapias celulares
CN103298939A (zh) * 2010-12-06 2013-09-11 夸克医药公司 包含位置修饰的双链寡核苷酸化合物
WO2012095743A2 (en) 2011-01-12 2012-07-19 Cellerix Sa Methods and compositions for use in intralymphatic cellular therapies
ES2479565T1 (es) 2011-03-11 2014-08-20 Tigenix, S.A.U. Poblaciones celulares que tienen actividad immunoreguladora, método para el aislamiento y usos
US20140134140A1 (en) 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
CA2906299C (en) * 2013-03-15 2023-04-04 Tigenix, S.A.U Lymphocyte biomarkers for determining the clinical response to cell therapy
US20160120910A1 (en) 2013-06-25 2016-05-05 Tigenix S.A.U. Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
CA2953884C (en) * 2014-06-30 2022-12-06 Tigenix S.A.U. Mesenchymal stromal cells for treating sepsis
AU2016327285A1 (en) * 2015-09-24 2018-04-12 Cellect Biotherapeutics Ltd. Methods for propagating mesenchymal stem cells (MSC) for use in transplantation
GB201604304D0 (en) * 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US10152822B2 (en) 2017-04-01 2018-12-11 Intel Corporation Motion biased foveated renderer
US10890966B2 (en) 2017-07-27 2021-01-12 Arm Limited Graphics processing systems
US10818080B2 (en) 2018-07-25 2020-10-27 Disney Enterprises, Inc. Piecewise-polynomial coupling layers for warp-predicting neural networks
US11109065B2 (en) 2018-09-26 2021-08-31 Google Llc Video encoding by providing geometric proxies

Also Published As

Publication number Publication date
DE102017002458A1 (de) 2017-09-14
ES2681774B1 (es) 2019-12-26
KR102277789B1 (ko) 2021-07-15
US20170258851A1 (en) 2017-09-14
IL261730B1 (en) 2024-01-01
DK3219321T3 (da) 2022-04-25
CA3017694A1 (en) 2017-09-21
RS63163B1 (sr) 2022-05-31
HUE058739T2 (hu) 2022-09-28
LT3219321T (lt) 2022-05-10
US20220249574A1 (en) 2022-08-11
IL261730B2 (en) 2024-05-01
EP4074322A1 (en) 2022-10-19
SG10202008992YA (en) 2020-10-29
BE1024781B1 (de) 2018-07-02
GB201704065D0 (en) 2017-04-26
IL298107B2 (en) 2024-02-01
CN115569151A (zh) 2023-01-06
IL298107A (en) 2023-01-01
FR3048614A1 (enExample) 2017-09-15
AU2017232718A1 (en) 2018-10-04
NL2018512B1 (en) 2017-09-07
ES2911718T3 (es) 2022-05-20
NL2018512A (en) 2017-03-30
GB2548490A (en) 2017-09-20
MX2018010699A (es) 2019-01-14
BE1024781A1 (de) 2018-06-27
CA3017694C (en) 2024-02-27
GB2548490B (en) 2020-09-02
NO345415B1 (en) 2021-01-18
US20190381106A1 (en) 2019-12-19
ES2681774A1 (es) 2018-09-14
RU2018131519A3 (enExample) 2020-07-10
HRP20220539T1 (hr) 2022-06-10
SI3219321T1 (sl) 2022-05-31
IL261730A (en) 2018-10-31
US11273182B2 (en) 2022-03-15
US12213998B2 (en) 2025-02-04
DE102017002458B4 (de) 2019-04-25
JP2019508455A (ja) 2019-03-28
RU2742308C2 (ru) 2021-02-04
CN108883135B (zh) 2022-11-04
JP2021119789A (ja) 2021-08-19
CY1125513T1 (el) 2024-12-13
BR112018068493A8 (pt) 2022-06-28
JP6931656B2 (ja) 2021-09-08
BR112018068493A2 (pt) 2019-01-22
IL298107B1 (en) 2023-10-01
KR20180120261A (ko) 2018-11-05
NO20170376A1 (en) 2017-09-15
EP3219321A1 (en) 2017-09-20
US10357518B2 (en) 2019-07-23
AU2017232718B2 (en) 2024-01-18
RU2018131519A (ru) 2020-04-15
CN108883135A (zh) 2018-11-23
SG11201807404XA (en) 2018-09-27
GB201604304D0 (en) 2016-04-27
EP3219321B1 (en) 2022-03-30
WO2017158509A1 (en) 2017-09-21
PL3219321T3 (pl) 2022-05-30

Similar Documents

Publication Publication Date Title
FR3048614B1 (fr) Cellules souches stromales derivees du tissu adipeux pour une utilisation dans le traitement des fistules peri-anales complexes refractaires dans la maladie de crohn
EP3479831A4 (en) COMPOSITION WITH THROMBINE-TREATED STEM CELL-DERIVED EXOSOM FOR THE TREATMENT OF SKIN Wounds
ZA202002775B (en) Cultivation of placenta to isolate exosomes
EP3692909A4 (en) DIFFERENTIATION DEVICE, DEPRESSION SYMPTOMS DIFFERENTIATION PROCESS, DEPRESSION SYMPTOM LEVEL DETERMINATION METHOD, DEPRESSION PATIENT STRATIFICATION METHOD, DEPRESSION SYMPTOM TREATMENT EFFECTS DETERMINATION AND DEPRESSION SYMPTOMS TREATMENT PROCESS, DETERMINATION DEVICE '' BRAIN ACTIVITY
MA52575A (fr) Pansement pour le traitement de la peau endommagée
DOP2012000297A (es) Agentes inductores de apoptosis para el tratamiento del cancer y de enfermedades inmunes y autoinmunes
EP3443966A4 (en) COMPOSITION FOR THE TREATMENT OF CHRONIC LUNG DISEASE WITH EXOSOM FROM THROMBINE-TREATED STEM CELLS
UY33047A (es) Agentes inductores de apoptosis para el tratamiento del cáncer y de enfermedades inmunes y autoinmunes
EP3504187A4 (en) USE OF PRIDOPIDIN FOR THE TREATMENT OF FUNCTIONAL DECAY
EP4275746A3 (en) Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
MA38253A1 (fr) Compositions comprenant de la vortioxétine et du donépézil
MA46548A (fr) Fsh pour le traitement de l'infertilité
MA53268A (fr) Mini-gde pour le traitement de la maladie de stockage du glycogène iii
MX2019012738A (es) Peptido para inducir la regeneracion de tejido, y uso del mismo.
EA201692518A2 (ru) Способы улучшения производительности миокарда у пациентов после операции фонтена с применением композиций уденафила
EP3344071A4 (en) COMBINED COMPOSITIONS FOR CONTROLLING BLOOD SUGAR MIRRORS, LIVER PROTECTION AND PREVENTING AND TREATING RELATED MEDICAL CONDITIONS
GB201212111D0 (en) Vascular bed-specific endothelial cells
SG11201804307WA (en) Therapeutic agent for liver disease containing stromal cells derived from adipose tissue and method for producing the same
EA201792603A1 (ru) Ангиогенез с использованием стимулированных плацентарных стволовых клеток
EP3681517A4 (en) METHODS FOR IMPROVING ORGAN FUNCTION IN ORGAN TRANSPLANT PATIENTS
EP3883972A4 (en) POLYPEPTIDE FOR TREATMENT OF PATHOLOGICAL BLOOD CLOTS
MA37821A1 (fr) Utilisation d'inhibiteurs de vegfr-3 destinés au traitement du carcinome hépatocellulaire
EP3310310A4 (en) DEVICE FOR TREATING MENIÈRE DISEASE
EP3364959A4 (en) COMPOSITION FOR THE TREATMENT OF BARRENESS IN FEMALE SUBJECTS
EP3909591A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PANCREATITIS WITH CLONAL STEM CELLS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190308

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

TP Transmission of property

Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP

Effective date: 20220914

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9